Global Attention Deficit Hyperactivity Disorder (ADHD) Market: Industry Analysis & Outlook (2018-2022)

Publisher Name :
Date: 06-Aug-2018
No. of pages: 74
Inquire Before Buying

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that impacts an individual ability to focus, self-control and perform other skills important in daily life. ADHD is caused due to biochemical, connectivity and the structural difference in the mind. Symptoms of the Attention Deficit Hyperactivity Disorder (ADHD) mostly advances over a period of time and varies according to the type of causing factor and according to the age group of the person. The common symptoms in patient population are trouble at work, low self-esteem and substance abuse or addiction, low-stress tolerance level, mood swings and many more. Further, on the basis of symptoms, ADHD is classified into three key categories including the predominantly inattentive, predominantly hyperactive-impulsive and combined type. ADHD is diagnosed using a comprehensive evaluation of the patient mental and behavior condition. Various treatment options are pharmacological treatment, educational interventions & other behavioral therapies and EEG biofeedback therapies, physicians could reduce the disorder symptoms and its effects on the individual health.

The U.S. emerged as a major region for the ADHD market due to increased healthcare expenditure incurred on the treatment & diagnosis of the ADHD patients and growth in the number of hospitals & clinics offering EEG biofeedback & dual therapy.

The global attention deficit hyperactivity disorder (ADHD) market is expected to grow with increasing pharmaceutical R&D spending, growing healthcare expenditure, accelerating economic growth, unmet treatment needs and mounting occurrence of ADHD. Key trends and developments of this market includes progressing drugs under pipeline, high demand for dual therapy and rising preference for EEG biofeedback therapy. However, there are some factors which can hinder growth of the market including Medical complications of existing drug therapies, high domination of generic pharmaceutical market and strict government protocols.

The report “Global Attention Deficit Hyperactivity Disorder (ADHD) Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers, key tends & developments and challenges of the market, covering the U.S., Europe along with the global market. The report profiles the key players of the market including Shire Plc, Johnson and Johnson, Eli Lilly and Company and Novartis International AG.

Global Attention Deficit Hyperactivity Disorder (ADHD) Market: Industry Analysis & Outlook (2018-2022)

Table of Contents

1. ADHD Overview
1.1 Introduction
1.2 Causes
1.3 Symptoms
1.4 Classification
1.5 Diagnosis
1.6 Treatment

2. Global ADHD Market
2.1 Global ADHD Market Value Forecast
2.2 Global ADHD Market Value by Region
2.3 Global ADHD Patient Population Forecast

3. Regional ADHD Market
3.1 The U.S.
3.1.1 The U.S. ADHD Market Value
3.1.2 The U.S. ADHD Market Value Forecast
3.1.3 The U.S. ADHD Market Revenue by Drugs
3.1.4 The U.S. Vyvanse Drug Revenue Forecast
3.1.5 The U.S. Adderall Generics (IR & XR) Drug Revenue Forecast
3.1.6 The U.S. Adderall XR Drug Revenue Forecast
3.1.7 The U.S. ADHD Drugs Revenue by Categories
3.1.8 The U.S. ADHD Adult Patient Population Forecast
3.1.9 The U.S. ADHD Total Prescriptions
3.1.10 The U.S. ADHD Total Prescriptions Forecast
3.1.11 The U.S. ADHD Total Prescriptions by Drugs
3.1.12 The U.S. Adderall Generics (IR & XR) Total Prescriptions Forecast
3.1.13 The U.S. Vyvanse Total Prescriptions Forecast
3.1.14 The U.S. Concerta Total Prescriptions Forecast
3.2 Europe
3.2.1 Europe ADHD Market Value Forecast
3.2.2 Europe ADHD Patient Population Forecast

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Pharmaceutical R&D Spending
4.1.2 Growing Healthcare Expenditure
4.1.3 Accelerating Economic Growth
4.1.4 Unmet Treatment Needs
4.1.5 Mounting Occurrence of ADHD
4.2 Key Trends and Developments
4.2.1 Progressing Drugs under Pipeline
4.2.2 High Demand for Dual Therapy
4.2.3 Rising Preference for EEG Biofeedback Therapy
4.3 Challenges
4.3.1 Medical Complications of Existing Drug Therapies
4.3.2 High Domination of Generic Pharmaceutical Market
4.3.3 Strict Government Protocols

5. Competitive Landscape
5.1 Global ADHD Market
5.1.1 Key Players – Revenues Comparison
5.1.2 Key Players - Market Cap Comparison
5.1.3 Key Players – ADHD Prescription Cost Comparison

6. Company Profiles
6.1 Shire Plc
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Johnson and Johnson
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Eli Lilly and Company
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Novartis International AG
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

List of Tables

Drugs under Development for ADHD (2018)
Medical Complications of Existing Drug Therapies
Generic vs. Patented Drugs Price Comparison (2018)
Key Players – Revenues Comparison (2017)
Key Players – ADHD Prescription Cost Comparison (2018)
J&J Significant Agreements (2018/2017)

List of Figures

Categories of ADHD by Symptoms
Global ADHD Market Value Forecast (2017-2022)
Global ADHD Market Value by Region (2017)
Global ADHD Patient Population Forecast (2017-2022)
The U.S. ADHD Market Value (2013-2017)
The U.S. ADHD Market Value Forecast (2018-2022)
The U.S. ADHD Market Revenue by Drugs* (2017)
The U.S. Vyvanse Drug Revenue Forecast (2017-2022)
The U.S. Adderall Generics (IR & XR) Drug Revenue Forecast (2017-2022)
The U.S. Adderall XR Drug Revenue Forecast (2017-2022)
The U.S. ADHD Drugs Revenue by Categories (2017)
The U.S. ADHD Adult Patient Population Forecast (2017-2022)
The U.S. ADHD Total Prescriptions (2013-2017)
The U.S. ADHD Total Prescriptions Forecast (2018-2022)
The U.S. ADHD Total Prescriptions by Drugs (2017)
The U.S. Adderall Generics (IR & XR) Total Prescriptions Forecast (2017-2022)
The U.S. Vyvanse Total Prescriptions Forecast (2017-2022)
The U.S. Concerta Total Prescriptions Forecast (2017-2022)
Europe ADHD Market Value Forecast (2017-2022)
Europe ADHD Patient Population Forecast (2017-2022)
Global Pharmaceutical R&D Spending (2013-2017)
Global Healthcare Expenditure (2013-2017)
Global GDP Per Capita (2013-2017)
Key Players - Market Cap Comparison (2018*)
Shire Net Revenues by Therapeutic Areas (2017)
Shire Net Revenues and Net Income (2013-2017)
Shire R&D Expenditures (2015-2017)
Shire A&P Expenditures (2015-2017)
J&J Net Sales by Business Segments (2017)
J&J Net Sales and Net Earnings (2013-2017)
J&J R&D Expenditures (2015-2017)
Eli Lilly Revenues by Business Segments (2017)
Eli Lilly Revenues and Net Income (Loss) (2013-2017)
Eli Lilly A&P Expenditures (2015-2017)
Novartis Net Sales by Business Segments (2017)
Novartis Net Sales and Net Income (2013-2017)
Novartis R&D Expenditures (2015-2017)

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs